Regulators in the UK, Singapore, and South Korea are treating synthetic health data as non-personal only when residual disclosure risk is demonstrably low. For teams building or sharing synthetic datasets, the privacy bar is now explicit, not implied.
Regulators Set Conditions for Synthetic Health Data Sharing
Regulators in the UK, Singapore, and South Korea have issued guidance on when synthetic health data can be shared, and the message is consistent across jurisdictions: synthetic does not automatically mean anonymous. The key test is whether residual disclosure risk is demonstrably low, meaning organizations must be able to show that individuals cannot realistically be re-identified from the generated data. That shifts synthetic health data out of the marketing category and into a governed data product that still needs formal review before release.
For hospitals, research networks, healthtech vendors, and public-sector data holders, the practical burden is now clearer. Before sharing synthetic datasets with external partners, teams may need to document how the data was generated, what privacy controls were applied, how disclosure risk was evaluated, and whether the resulting dataset preserves enough utility for its intended use without exposing patients. In effect, the compliance question is no longer whether a dataset is synthetic, but whether the organization can defend the process and evidence behind it.
- Synthetic data programs now need documented risk assessments rather than broad claims that generation alone makes data safe to share.
- Teams moving health data across borders should expect jurisdiction-specific privacy review, because similar principles may be applied differently in the UK, Singapore, and South Korea.
- Model design, utility targets, privacy controls, and disclosure testing may all become part of the compliance record that regulators, auditors, or partners ask to see.
- Procurement, legal, and partnership teams may need to update data-sharing terms so approvals reflect residual-risk testing, permitted uses, and accountability for downstream handling.